Astellas

Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
Yahoo/MarketWire
Sat, 08/4/12 - 11:22 am
Medivation
Astellas
Enzalutamide
prostate cancer
Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA
Yahoo/Fly on the Wall
Tue, 07/24/12 - 09:41 am
Enzalutamide
Medivation
Astellas
prostate cancer
Prostate Cancer Treatment Seen Drawing Medivation Bids: Real M&A
Bloomberg
Mon, 07/16/12 - 08:48 am
prostate cancer
Medivation
M&A
AbbVie
Astellas
Enzalutamide
Astellas Bladder Treatment Wins U.S. Approval For Sale
Bloomberg
Thu, 06/28/12 - 06:04 pm
Astellas
FDA
overactive bladder
mirabegron
Medivation Emerges With New Prostate Cancer Drug
Xconomy
Thu, 05/31/12 - 10:17 am
Medivation
prostate cancer
MDV3100
Astellas
Medivation Files Enzalutamide NDA
Yahoo/Zacks
Tue, 05/22/12 - 11:16 am
Medivation
Astellas
prostate cancer
Enzalutamide
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Astellas Wins FDA Panel Backing for Overactive Bladder Drug
Bloomberg
Thu, 04/5/12 - 09:07 pm
FDA
overactive bladder
Astellas
mirabegron
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Bloomberg
Tue, 04/3/12 - 08:54 am
Astellas
overactive bladder
FDA
mirabegron
New Data Demonstrates DIFICLIR™ May Offer Benefits for Cancer Patients, who are at High Risk of Clostridium Difficile Infection
Sacramento Bee, CA
Sat, 03/31/12 - 01:03 pm
Dificid
Clostridium Difficile
Astellas
Astellas extends deal to sell Pfizer's Lipitor in Japan
Reuters
Thu, 03/29/12 - 10:02 am
Pfizer
Lipitor
statins
Japan
Astellas
Cardiome Investors: Why Shares Crashed 50%
Motley Fool
Tue, 03/20/12 - 10:02 am
Cardiome
Merck
Astellas
Vernakalant
Biotech Stocks To Watch In 2012
Seeking Alpha
Mon, 02/6/12 - 11:20 am
Astellas
Array Biopharma
AstraZeneca
Celldex
Exelixis
Pfizer
Progenics Pharmaceuticals
Seattle Genetics
Synta
IPO Preview: Verastem
Seeking Alpha
Wed, 01/25/12 - 12:36 pm
IPOs
Verastem
Astellas
GSK
Pfizer
Sanofi
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
Yahoo/MarketWire
Sat, 01/7/12 - 01:25 pm
Theravance
Astellas
Vibativ
antibiotics
Aveo Shares Decline Early After Cancer Data Misses Investor Expectations
Bloomberg
Tue, 01/3/12 - 11:31 am
Aveo Pharmaceutical
Astellas
renal cell carcinoma
tivozanib
Zogenix, Astellas to end co-promotion for migraine injection
Reuters
Wed, 12/21/11 - 08:35 am
Astellas
Zogenix
migraines
Sumavel DosePro
FDA, EMA accept Astellas bladder drug for review
Pharma Times, UK
Fri, 11/11/11 - 01:04 pm
FDA
EMA
overactive bladder
Astellas
mirabegron
Baker's Dozen Trying To Beat The Odds In Pancreatic Cancer
Seeking Alpha
Tue, 10/25/11 - 10:49 am
pancreatic cancer
Amgen
Celgene
Infinity
Oncolytics
Pharmacyclics
Immunomedics
Threshold Pharmaceuticals
Clovis Oncology
Novartis
Aduro BioTech
NewLink Genetics
Seattle Genetics
Bayer Schering
Astellas
Astellas halts development of anti-clotting drug
Reuters
Wed, 09/28/11 - 09:19 am
Astellas
YM150
anti-clotting

Pages